STAAR Surgical Company近日明确声明,其与相关方的合作协议中规定,若协议终止,任何一方均无需支付终止费用。该公司强调,其战略定位保持不变,将继续作为独立的公开上市公司运营。这一表态进一步巩固了STAAR在眼科医疗技术领域的自主发展路径。
STAAR Surgical Company近日明确声明,其与相关方的合作协议中规定,若协议终止,任何一方均无需支付终止费用。该公司强调,其战略定位保持不变,将继续作为独立的公开上市公司运营。这一表态进一步巩固了STAAR在眼科医疗技术领域的自主发展路径。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.